K
Kathryn J. Ritchie
Researcher at St. Vincent's Health System
Publications - 22
Citations - 1020
Kathryn J. Ritchie is an academic researcher from St. Vincent's Health System. The author has contributed to research in topics: Crohn's disease & Faecal calprotectin. The author has an hindex of 11, co-authored 22 publications receiving 870 citations. Previous affiliations of Kathryn J. Ritchie include University of Melbourne.
Papers
More filters
Journal ArticleDOI
Crohn's disease management after intestinal resection: a randomised trial
Peter De Cruz,Peter De Cruz,Michael A. Kamm,Michael A. Kamm,Amy L. Hamilton,Kathryn J. Ritchie,Efrosinia O. Krejany,Alexandra Gorelik,Danny Liew,Lani Prideaux,Ian C. Lawrance,Jane M. Andrews,Peter A. Bampton,Peter R. Gibson,Miles P. Sparrow,Rupert W. Leong,Timothy H. Florin,Richard B. Gearry,Graham L. Radford-Smith,Finlay A. Macrae,H.S. Debinski,Warwick Selby,Ian Kronborg,M. Johnston,Rodney Woods,P. Ross Elliott,Sally Bell,Steven J. Brown,William Connell,Paul V. Desmond +29 more
TL;DR: Treatment according to clinical risk of recurrence, with early colonoscopy and treatment step-up for recurrence), is better than conventional drug therapy alone for prevention of postoperative Crohn's disease recurrence.
Journal ArticleDOI
Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery
Emily K Wright,Emily K Wright,Michael A. Kamm,Michael A. Kamm,Peter De Cruz,Peter De Cruz,Amy L. Hamilton,Amy L. Hamilton,Kathryn J. Ritchie,Efrosinia O. Krejany,Steven T. Leach,Alexandra Gorelik,Danny Liew,Lani Prideaux,Lani Prideaux,Ian C. Lawrance,Ian C. Lawrance,Jane M. Andrews,Jane M. Andrews,Peter A. Bampton,Peter A. Bampton,Simon Jakobovits,Timothy H. Florin,Peter R. Gibson,H.S. Debinski,Finlay A. Macrae,Finlay A. Macrae,Douglas Samuel,Ian Kronborg,Graham L. Radford-Smith,Warwick Selby,M. Johnston,Rodney Woods,P. Ross Elliott,Sally Bell,Steven J. Brown,William Connell,Andrew S. Day,Paul V. Desmond,Paul V. Desmond,Richard B. Gearry +40 more
TL;DR: In this analysis of data from a prospective clinical trial, FC measurement has sufficient sensitivity and NPV values to monitor for CD recurrence after intestinal resection and its predictive value might be used to identify patients most likely to relapse.
Journal ArticleDOI
Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients – a POCER study analysis
P. De Cruz,Michael A. Kamm,Amy L. Hamilton,Kathryn J. Ritchie,Efrosinia O. Krejany,Alexandra Gorelik,Danny Liew,Lani Prideaux,Ian C. Lawrance,Jane M. Andrews,Peter A. Bampton,Simon Jakobovits,Timothy H. Florin,Peter R. Gibson,H.S. Debinski,Richard B. Gearry,Finlay A. Macrae,Rupert W. Leong,I.J. Kronborg,Graham L. Radford-Smith,Warwick Selby,Michael J. Johnston,Rodney Woods,Peter R. Elliott,Sally Bell,Stephanie Brown,William Connell,Paul V. Desmond +27 more
TL;DR: Crohn's disease recurs in the majority of patients after intestinal resection, and the likelihood of recurrence after resection is low.
Journal ArticleDOI
Microbial Factors Associated with Postoperative Crohn's Disease Recurrence.
Emily K Wright,Michael A. Kamm,Josef Wagner,Shu Mei Teo,Peter De Cruz,Amy L. Hamilton,Kathryn J. Ritchie,Michael Inouye,Carl D. Kirkwood +8 more
TL;DR: CD is associated with a microbial signature distinct from health and smoking independently influence postoperative CD recurrence, and the genus Proteus may play a role in the development of CD.
Journal ArticleDOI
Effect of intestinal resection on quality of life in Crohn's disease
Emily K Wright,Michael A. Kamm,Peter De Cruz,Amy L. Hamilton,Kathryn J. Ritchie,Efrosinia O. Krejany,Alexandra Gorelik,Danny Liew,Lani Prideaux,Ian C. Lawrance,Jane M. Andrews,Peter A. Bampton,Miles P. Sparrow,Timothy H. Florin,Peter R. Gibson,H.S. Debinski,Richard B. Gearry,Finlay A. Macrae,Rupert W. Leong,Ian Kronborg,Graeme Radford-Smith,Warwick Selby,Michael J. Johnston,Rodney Woods,P. Ross Elliott,Sally Bell,Steven J. Brown,William Connell,Paul V. Desmond +28 more
TL;DR: Intestinal resection of all macroscopic Crohn's disease in patients treated with postoperative prophylactic drug therapy is associated with significant and sustained improvement in HRQoL irrespective of type of drug treatment or endoscopic recurrence.